# Arlin B. Rogers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/arlin-b-rogers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,643 |
| Field | Helicobacter pylori-related gastroenterology studies |
| h-index | 55 |
| i10-index | 103 |
| Last Known Institution | Alnylam Pharmaceuticals (United States) |
| OpenAlex ID | https://openalex.org/A5109055060 |
| Works | 201 |

## Researcher papers

- [Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences](https://scholariq.org/papers/altering-the-intestinal-microbiota-during-a-critical-developmental-window-has/)

## Researcher topics

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)

## Researcher university

- [Alnylam Pharmaceuticals (United States)](https://scholariq.org/institutions/alnylam-pharmaceuticals-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.